Who we are
Kyomed at a Glance
- Private company
- Awarded in 2013 by the ‘Investments for the Future’ Program launched by French government
- Created in April 2014
- Expertise: Digital and molecular biomarkers & e-health
- Mission: to optimize and accelerate innovation in the field of personalized medicine.
The appeal of personalized medicine is the opportunity to provide the right drug or non-drug treatment to the right patient at the right time. Our comprehensive approach putting people at the center of attention and integrating expertise in biomarkers and digital technologies allows us to address tomorrow’s medical challenges.
“We build bridges between entrepreneurs, scientists, industry, experts in information communications technologies, healthcare professionals and patients to better shape tomorrow’s medicine. Our role to pilot multi-partner projects by assembling various scientific, technical, medical, regulatory and business expertise: the right expertise at the right time for a time-saving and cost-effective approach.”
Daniel Laune, CEO Kyomed
|Kyomed has been Research Tax Credit approved for 2015, 2016 and 2017 (CIR).|